Semaglutide could be a significant tool in the weight loss battle for some, however popular media reporting of the skinny jab may raise unrealistic expectations of easy weight loss within the general public
these include exercise interventions, cryotherapy, and compression therapy (Dan 2024)
Jamey Millar, Executive Vice President, US Operations, Novo Nordisk, said: For many older Americans living with obesity, this is a moment they and their families have been waiting for
Yui, K., Sato, A., & Imataka, G
Theres little scientific evidence to support it so far, but its a very valid hypothesis, he said